Recent findings suggest that N-myristoylation, particularly through the upregulation of N-myristoyltransferase 1 (NMT1) in hypoxic tumor environments, could play a pivotal role in cancer progression, given its involvement in cell proliferation, the cell cycle, and death pathways [23]. The gene discussed is NMT1; the disease is neoplasm.